HC Wainwright & Co. Reiterates Buy on Immunocore Hldgs, Maintains $90 Price Target
HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $90 price target.
HC Wainwright & Co. Reiterates Neutral on Eliem Therapeutics, Maintains $6 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Eliem Therapeutics (NASDAQ:ELYM) with a Neutral and maintains $6 price target.
HC Wainwright & Co. Reiterates Buy on Corbus Pharmaceuticals, Maintains $3 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy and maintains $3 price target.
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates ProPhase Labs (NASDAQ:PRPH) with a Buy and maintains $15 price target.
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $30 Price Target
HC Wainwright & Co. analyst Andres Maldonado reiterates Scholar Rock Holding (NASDAQ:SRRK) with a Buy and maintains $30 price target.
Needham Reiterates Buy on Tremor Intl, Maintains $10 Price Target
Needham analyst Laura Martin reiterates Tremor Intl (NASDAQ:TRMR) with a Buy and maintains $10 price target.
Needham Reiterates Buy on Alphabet, Maintains $115 Price Target
Needham analyst Laura Martin reiterates Alphabet (NASDAQ:GOOGL) with a Buy and maintains $115 price target.
TD Cowen Reiterates Market Perform on First Watch Restaurant Gr, Maintains $17 Price Target
TD Cowen analyst Andrew Charles reiterates First Watch Restaurant Gr (NASDAQ:FWRG) with a Market Perform and maintains $17 price target.
Telsey Advisory Group Reiterates Market Perform on Stitch Fix, Maintains $5 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates Stitch Fix (NASDAQ:SFIX) with a Market Perform and maintains $5 price target.
Chardan Capital Reiterates Buy on Freight Technologies, Maintains $2 Price Target
Chardan Capital analyst Brian Dobson reiterates Freight Technologies (NASDAQ:FRGT) with a Buy and maintains $2 price target.